No connection

Search Results

MXL

NEUTRAL
$21.56 Live
MaxLinear, Inc. · NASDAQ
Target $21.55 (-0.0%)
$9.07 52W Range $21.63

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 15, 2026
Market cap
$1.93B
P/E
N/A
ROE
-28.2%
Profit margin
-29.2%
Debt/Equity
0.32
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
75%
MXL exhibits a stark dichotomy between explosive top-line growth and poor fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While the company has achieved a massive 117.8% 1-year price increase and 48% YoY revenue growth, it continues to struggle with negative profit margins (-29.23%) and a low quick ratio (0.64). The stock is currently trading at its 52-week high, leaving little room for immediate upside given that the analyst target price ($21.55) aligns exactly with the current market price. The transition toward positive EPS is promising, but the deterministic health scores suggest significant underlying operational instability.

Key Strengths

Exceptional YoY revenue growth of 48.00%
Strong gross margins at 56.84%
Positive momentum in earnings surprises (3/4 beats in last year)
Low Debt/Equity ratio (0.32) indicating manageable leverage
Significant 1-year price recovery (+117.8%)

Key Risks

Very weak Piotroski F-Score (2/9) indicating poor financial health
Negative net profit margins (-29.23%) and ROE (-28.23%)
Bearish insider activity with CFO and Director selling shares
Low quick ratio (0.64) suggesting potential short-term liquidity pressure
Price is currently capped at the 52-week high with no analyst upside
AI Fair Value Estimate
Based on comprehensive analysis
$21.5
-0.3% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
35
Weak
Value
40
Future
85
Past
30
Health
20
Dividend
0
AI Verdict
Speculative Recovery
Key drivers: Revenue acceleration, EPS turnaround, Poor fundamental health scores, Insider selling
Confidence
80%
Value
40/100

Trades at a premium to book value; valuation is driven by growth expectations rather than current earnings.

Positives
  • Reasonable Forward P/E of 18.98
Watchpoints
  • High Price/Book (4.12)
  • High Price/Sales (4.13)
  • No Graham Number available due to lack of earnings
Future
85/100

Strong growth trajectory and successful pivot toward profitability.

Positives
  • 48% YoY Revenue growth
  • 311% YoY EPS growth
  • Consistent recent earnings beats
Watchpoints
  • Sustainability of growth in semiconductor cycle
Past
30/100

Long-term value destruction offset by a recent sharp recovery.

Positives
  • Strong 1-year recovery
Watchpoints
  • 5-year change of -42.6%
  • History of negative earnings quarters
Health
20/100

Deterministic health scores are critically low, signaling operational weakness.

Positives
  • Low Debt/Equity
Watchpoints
  • Piotroski F-Score of 2/9
  • Negative ROA and ROE
  • Quick ratio below 1.0
Dividend
0/100

Non-dividend paying growth stock.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$21.56
Analyst Target
$21.55
Upside/Downside
-0.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for MXL and closest competitors.

Updated 2026-04-14
MXL
MaxLinear, Inc.
Primary
5Y
-42.6%
3Y
-31.6%
1Y
+117.8%
6M
+27.7%
1M
+24.5%
1W
+17.1%
AGY
Agilysys, Inc.
Peer
5Y
+17.1%
3Y
-15.7%
1Y
-4.1%
6M
-35.3%
1M
-20.0%
1W
-11.6%
ALK
Alkami Technology, Inc.
Peer
5Y
-58.1%
3Y
+42.7%
1Y
-28.7%
6M
-28.8%
1M
+6.8%
1W
+5.5%
FOR
Formula Systems (1985) Ltd.
Peer
5Y
+46.6%
3Y
+103.2%
1Y
+45.4%
6M
-16.8%
1M
-2.9%
1W
-0.3%
DGI
Digi International Inc.
Peer
5Y
+180.4%
3Y
+55.5%
1Y
+116.1%
6M
+47.1%
1M
+5.2%
1W
+8.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
18.98
PEG Ratio
N/A
P/B Ratio
4.12
P/S Ratio
4.13
EV/Revenue
4.14
EV/EBITDA
-33.17
Market Cap
$1.93B

Profitability

Profit margins and return metrics

Profit Margin -29.23%
Operating Margin -11.06%
Gross Margin 56.84%
ROE -28.23%
ROA -7.7%

Growth

Revenue and earnings growth rates

Revenue Growth +48.0%
Earnings Growth N/A
Q/Q Revenue Growth +48.03%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.32
Low debt
Current Ratio
1.34
Good
Quick Ratio
0.64
Poor
Cash/Share
$0.84

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.1B
Gross Margin
57.6%
Op. Margin
-11.1%
Net Margin
-10.9%
Total Assets
$0.8B
Liabilities
$0.3B
Equity
$0.5B
Debt/Equity
0.76x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
65%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-23
$N/A
2026-01-29
$0.19
+6.3% surprise
2025-10-23
$0.14
+17.6% surprise
2025-07-23
$0.02
+8.5% surprise

Technology Sector Comparison

Comparing MXL against 490 companies in the Technology sector (40 bullish, 167 neutral, 283 bearish)
Return on Equity (ROE)
-28.23%
This Stock
vs
-34.81%
Sector Avg
-18.9% (Below Avg)
Profit Margin
-29.23%
This Stock
vs
-12.62%
Sector Avg
+131.5% (Superior)
Debt to Equity
0.32
This Stock
vs
0.71
Sector Avg
-55.0% (Less Debt)
Revenue Growth
48.0%
This Stock
vs
5058.57%
Sector Avg
-99.1% (Slower)
Current Ratio
1.34
This Stock
vs
3.77
Sector Avg
-64.5% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

LITCHFIELD STEVEN G
Chief Financial Officer
Sell
2026-03-06
44,929 shares · $746,427
SEENDRIPU KISHORE V
Chief Executive Officer
Stock Award
2026-03-02
90,426 shares
KWONG CONNIE H.
Officer
Stock Award
2026-03-02
6,231 shares
SEENDRIPU KISHORE V
Chief Executive Officer
Stock Award
2026-02-20
105,867 shares
KWONG CONNIE H.
Officer
Stock Award
2026-02-20
10,933 shares
LITCHFIELD STEVEN G
Chief Financial Officer
Stock Award
2026-02-20
45,419 shares
LITCHFIELD STEVEN G
Chief Financial Officer
Stock Award
2026-02-20
29,315 shares
ARTUSI DANIEL A
Director
Sell
2025-10-30
29,802 shares · $463,051
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
10 analysts
Wells Fargo
2026-01-30
Maintains
Equal-Weight Equal-Weight
Benchmark
2026-01-16
Maintains
Buy Buy
Benchmark
2025-10-24
reit
Buy Buy
Benchmark
2025-10-17
reit
Buy Buy

Past News Coverage

Recent headlines mentioning MXL from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile